I am currently the LGC Professor in Measurement Science for Health and lead the Centre for Advanced Measurement and Health Translation - a joint initiative with the National Measurement Laboratory (NML) at the Laboratory of the Government Chemist (LGC) and the University of Stathclyde. The aim of the centre is to develop cutting edge interdisciplinary projects which drive new healthcare and measurement science R&D in Scotland.

Using my core expertise in electrochemical sensing, analytical chemistry and device fabrication my research aims to develop improved diagnostic tests for clinically important conditions such as, drug resistant bacterial infections, COVID-19, sepsis, cancer and epilepsy.  In the group we work on a range of sensor systems, from high value microfabricated arrays, to wearables and through to low cost devices for use in resource limited settings.

In addition to academic research, translational activity is an important aspect of the group's work because we are keen to ensure that developments from the lab ultimately find real world application.  As a result of this, I am co-founder of two spin-out companies (Aureum Diagnostics and Microplate Dx) and centrally involved in their onging R&D activity. My work is often highly interdisciplinary involving industrial partners (e.g. GSK, National Nuclear Laboratory, AstraZeneca, Lifescan, Aptamer Group, FlexMedical Solutions, Biotangents and other SMEs) and projects rely on close collaboration with other academics, including: clinicians, microbiologists, neuroscientists, electrical engineers and chemists.

I have a varied teaching history having led and delivered modules in the areas of: Cell Biology, Biophysical Chemistry, Biotechniques, Analytical Chemistry and Medical Diagnostics.